Australia TGA ARTG record

HYALO4 Start Ointment - Epidermal osmotic dressing, non-sterile

Australia TGA ARTG Registered Device · Ainscorp Pty Ltd · Fidia Farmaceutici SPA · Class III · Started January 19, 2021

Good Name: Ainscorp Pty Ltd - HYALO4 Start Ointment - Epidermal osmotic dressing, non-sterile

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: January 19, 2021
Effective Date: January 19, 2021

Sponsor

Name: Ainscorp Pty Ltd

Manufacturer

Name: Fidia Farmaceutici SPA
Country: Italy
Address: Via Ponte Della Fabbrica 3/A, Abano Terme, Padova, 35031

Intended purpose

For the local management of chronic ulcers (i.e. pressure sores, vascular ulcers of the legs, diabetic ulcers). In particular, it is intended to provide an optimal moist environment and wound bed preparation that supports the natural healing process.

About this record

Access comprehensive regulatory information for HYALO4 Start Ointment - Epidermal osmotic dressing, non-sterile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Ainscorp Pty Ltd, manufactured by Fidia Farmaceutici SPA in Italy. The device registration started on January 19, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.